<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="../../web/xslt/drug-table.xslt"?><drug name = "brentuximab inj VIAL>
<dose><value>1.8</value>
<value>1.2</value>
</dose><route><value>IV</value>
</route><form><value>inj VIAL</value>
</form><drug><value>brentuximab inj VIAL</value>
</drug><strength><value>50 mg</value>
</strength><frequency><value>ONCE</value>
</frequency><instruction><value></value>
</instruction><volume><value></value>
</volume><units><value>mg/kg</value>
</units><additionalnotes><value>Maximum dosing weight is 100 kg with a maximum dose of 180 mg. Recommend dosage reduction to 1.2 mg/kg in patients with mild hepatic impairment (Child-Pugh Class A) or patients with periperal neuropathy (new or worsening) Grade 2 or 3. </value>
</additionalnotes><population><value>ADULT</value>
</population><indicationprn><value></value>
</indicationprn><backgroundinformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=6601</value>
</backgroundinformation><prninformation><value></value>
</prninformation><ahsformularystatus><value>Formulary with Restrictions.</value>
</ahsformularystatus><ahfsname><value>Antineoplastic Agents</value>
</ahfsname><highalert><value>YES</value>
</highalert><maximumprndose><value>YES</value>
</maximumprndose></drug>